02 May 2003
Cloning and characterization of the bidirectional promoter regulating the expression of the human poly(ADP-ribose) glycohydrolase (PARG) and inner mitochondrial membrane translocase 23 (TIM23) genes
M. Meyer-Ficca, R. Meyer, E. Jacobson, M. JacobsonMed Sci Monit 2003; 9(1): 44-0 :: ID: 15107
Abstract
Poly(ADP-ribosyl)ation is a posttranslational protein modification mediated by a family of poly(ADP-ribose) polymerases (PARPs). It is a highly energy-consuming process which can ultimately lead to depletion of cellular NAD+ pools and thereby to cell death. Poly(ADP-ribose) glycohydrolase (PARG) is the only known cellular ADP-ribose polymer degrading enzyme, thus the turnover of poly(ADP-ribose) appears to be dependent on the availability of cellular PARG. By computational analysis of the genomic locus of the human PARG gene, we identified a 470 bp bidirectional putative common promoter for the PARG and the TIM23 genes. The complete promoter was amplified by PCR of genomic DNA of human CF3 fibroblasts, sequenced and cloned into the reporter plasmid pGFL, in both PARG and TIM23 orientations. Transfection of these reporter plasmids into HEK293 cells allowed the determination of the respective promoter activities. The TIM23 promoter showed a 3.7 fold higher activity than the PARG promoter, suggesting different expression levels for these proteins. TIM23 promoter activity reached 30% of a RSV promoter control plasmid, while PARG promoter activity was 10% of the control. Detailed analysis of the promoter sequence indicates the presence of putative binding sites for transcription factors NF-kB, c-ETS-1, CREBP, MyoD and SP1. Promoter mutants lacking different putative transcription factor binding sites are currently under investigation to further elucidate the regulation of PARG expression and the possibility of a coregulation of PARG and TIM23 expression.
Keywords: poly(ADP-ribose)glycohydrolase, PARG, inner mitochondrial membrane translocase 23, TIM23, bidirectional common promoter
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952